In a foundational 2003 study, Khavinson et al
Kronenberg G, Bick-Sander A, Bunk E, Wolf C, Ehninger D, Kempermann G
Epithalon is strictly for in-vitro laboratory and scientific research use only
Moreover, these HLCs displayed significant CYP450 metabolic activities for CYP3A4, CYP2C9, and CYP2D6, similar to PHs
Athletes with low or borderline serum B12 (under 300 pg/mL) typically see measurable performance recovery within 8 to 12 weeks of supplementation
Practitioners are already using this approach with success in: Autoimmune conditions (like arthritis, Hashimotos, and celiac-related issues) Post-COVID complications (including Long COVID and MIS-C) Metabolic dysfunction (insulin resistance, chronic inflammation) Neurological issues (brain fog, mood changes from gut-brain disruption) What Research Shows Clinical studies on Larazotide demonstrate: A measurable reduction in gut permeability markers Improved gut symptom scores Lower inflammatory cytokine levels A strong safety record with minimal side effects Patients typically notice improvement in 714 days , with full benefits within 46 weeks